601514-58-3Relevant articles and documents
Compounds and methods of use
-
Page/Page column 1048; 1049; 1052; 1053; 1056; 1057, (2021/08/04)
Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein X1, X2, X3, X4, Y, A, L1, L2, R1, R2, R5, m and n are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.
Substituted tetrahydroisoquinoline compound and application
-
, (2017/07/23)
The invention discloses a substituted tetrahydroisoquinoline compound and application. The compound has a structure as shown in a general formula I in the specification; and in the general formula I, substituents are defined in the specification. The comp
Tetrahydroquinilinones, tetrahydronaphthyridones and derivatives thereof
-
Page/Page column 8, (2008/12/06)
Tetrahydroquinolinone and tetrahydronaphthyridone cannabinoid receptor ligand compounds and stereoisomers, mixtures of stereoisomers, prodrugs, pharmaceutically acceptable salts, hydrates, solvates, acid salt hydrates, and isomorphic crystalline forms the